Of text and gene - using text mining methods to uncover hidden knowledge in toxicogenomics

BMC Systems Biology

Volumn 8, Issue 1, 2014, Pages

  Lee, Mikyung ^a   Liu, Zhichao ^a   Kelly, Reagan ^a   Tong, Weida ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Latent dirichlet allocation; Systems biology; Text mining; Topic modeling; Toxicogenomics

Indexed keywords

BIOLOGY; DATA MINING; DNA MICROARRAY; DOSE RESPONSE; HUMAN; PROCEDURES; TIME; TOXICOGENETICS;

COMPUTATIONAL BIOLOGY; DATA MINING; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TIME FACTORS; TOXICOGENETICS;

EID: 84908092737     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/s12918-014-0093-3     Document Type: Article

References (23)

1. Applications of toxicogenomic technologies to predictive toxicology and risk assessment 2007, National Academies Press, Washington, DC.
2. Chen M, Zhang M, Borlak J, Tong W. A decade of toxicogenomic research and its contribution to toxicological science. Toxicol Sci 2012, 130(2):217-228. 10.1093/toxsci/kfs223, 22790972.
3. Wang HJ, Ding Y, Tang J, Dong XA, He B, Qiu J, Wild DJ. Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA. PLoS One 2011, 6(3):e17243. 10.1371/journal.pone.0017243, 21448266.
4. Bisgin H, Liu Z, Fang H, Xu X, Tong W. Mining FDA drug labels using an unsupervised learning technique - topic modeling. BMC Bioinformatics 2011, 12(Suppl 10):S11. 10.1186/1471-2105-12-S10-S11, 22166012.
5. Bisgin H, Liu Z, Kelly R, Fang H, Xu X, Tong W. Investigating drug repositioning opportunities in FDA drug labels through topic modeling. BMC Bioinformatics 2012, 13(Suppl 15):S6. 10.1186/1471-2105-13-S15-S6, 23046522.
6. Manuele B, Pietro L, Barbara O, Alessandro P. Expression microarray classification using topic models. Proceedings of the 2010 ACM Symposium on Applied Computing 2010, ACM, Sierre, Switzerland.
7. Flaherty P, Giaever G, Kumm J, Jordan MI, Arkin AP. A latent variable model for chemogenomic profiling. Bioinformatics 2005, 21(15):3286-3293. 10.1093/bioinformatics/bti515, 15919724.
8. Liu B, Liu L, Tsykin A, Goodall GJ, Green JE, Zhu M, Kim CH, Li J. Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics 2010, 26(24):3105-3111. 10.1093/bioinformatics/btq576, 20956247.
9. Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T. The Japanese toxicogenomics project: Application of toxicogenomics. Mol Nutr Food Res 2010, 54(2):218-227. 10.1002/mnfr.200900169, 20041446.
10. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM, Speed TP, Akil H, Watson SJ, Meng F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005, 33(20):e175. 10.1093/nar/gni179, 16284200.
11. Hochreiter S, Clevert D-A, Obermayer K. A new summarization method for affymetrix probe level data. Bioinformatics 2006, 22(8):943-949. 10.1093/bioinformatics/btl033, 16473874.
12. David MB, Andrew YN, Michael IJ. Latent dirichlet allocation. J Mach Learn Res 2003, 3:993-1022.
13. Kullback S. Information theory and statistics 1959, John Wiley and Sons, NY.
14. Bader G, Hogue C. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003, 4(1):2. 10.1186/1471-2105-4-2, 12525261.
15. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci 2001, 98(20):11462-11467. 10.1073/pnas.201162998, 11562467.
16. Dip R, Lenz S, Gmuender H, Naegeli H. Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol 2009, 47(4):787-795. 10.1016/j.fct.2009.01.008, 19167446.
17. Mathijs K, Brauers KJJ, Jennen DGJ, Boorsma A, Van Herwijnen MHM, Gottschalk RWH, Kleinjans JCS, Van Delft JHM. Discrimination for Genotoxic and Nongenotoxic Carcinogens by Gene Expression Profiling in Primary Mouse Hepatocytes Improves with Exposure Time. Toxicol Sci 2009, 112(2):374-384. 10.1093/toxsci/kfp229, 19770486.
18. Chen MJ, Vijay V, Shi Q, Liu ZC, Fang H, Tong WD. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today 2011, 16(15-16):697-703. 10.1016/j.drudis.2011.05.007, 21624500.
19. Kunishima C, Inoue I, Oikawa T, Nakajima H, Komoda T, Katayama S. Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors. PPAR Res 2007, 2007:1-5. 10.1155/2007/36092.
20. Tamura K, Ono A, Miyagishima T, Nagao T, Urushidani T. Profiling of gene expression in rat liver and rat primary cultured hepatocytes treated with peroxisome proliferators. J Toxicol Sci 2006, 31(5):471-490. 10.2131/jts.31.471, 17202761.
21. Haddow A, Weinhouse S. Advances in cancer research. vol 7 1963, Academic Press Inc, NY.
22. Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat Res 2008, 637(1-2):23-39. 10.1016/j.mrfmmm.2007.06.010, 17689568.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102(43):15545-15550. 10.1073/pnas.0506580102, 16199517.